iKang prices Nasdaq IPO at top end

The Chinese healthcare group benefits from renewed buying interest in mainland stocks.

iKang prices Nasdaq IPO at top end

iKang Healthcare Group has raised $153 million after pricing its US IPO at the top end of its $12 to $14 indicative price range. A 10.9 million ADR offering was priced at $14 per unit just after the New York close on Tuesday by joint leads Bank of America Merrill Lynch and UBS.

Two ADS units equal one share and there is also a 15% overallotment option. The institutional book is said to have...

To continue reading, please login or register for free

Click for more on: ikang healthcare group | ikang | ipo

Print Edition

FinanceAsia Print Edition

CONFERENCES

  • Green Bonds Southeast Asia

    25 May 2017  |  Singapore
    With Green Bonds globally reaching USD200 billion outstanding in 2016, from as little as 30bn just 4 years ago, can SE Asia corporations and ...
  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...